FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 4132353 · Received October 1, 2014

Report

Report Number
2124215-2014-14756
Event Type
Injury
Date Received
October 1, 2014
Date of Event
March 7, 2014
Report Date
July 22, 2014
Manufacturer
CPI - DEL CARIBE
Product Code
DTB
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS RIGHT VENTRICULAR (RV) LEAD, AND ANOTHER MANUFACTURER'S DEVICE, PRESENTED TO THE EMERGENCY ROOM WITH PRE-SYNCOPE SYMPTOMS. INTERROGATION OF THE DEVICE FOUND RV LOSS OF CAPTURE. IT WAS REPORTED THE PATIENT'S SYMPTOMS CORRESPONDED TO AN INCREASE IN THRESHOLD MEASUREMENTS. THE LEAD WAS IMAGED AND THERE WAS NO SIGN OF A LEAD FRACTURE. AN INVASIVE PROCEDURE WAS PERFORMED. THE LEAD WAS SURGICALLY ABANDONED AND REPLACED WITH ANOTHER MANUFACTURER'S LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
612953 FINELINE II IMPLANTABLE LEAD DTB CPI - DEL CARIBE 4471

Patients

Seq Age Sex Outcome Treatment
1 76 YR Hospitalization| L| R 4471| 1298| 4470